Oncolytic virus and PD-1/PD-L1 blockade combination therapy
Oncolytic Virotherapy · 2018-07 · Volume 7 · 65-77
DOI: 10.2147/ov.s145532 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncolytic Virotherapy, 2018-07. Verfasst von Chun-Yu Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, Timothy.Cripe@nationwidechildrens.org. Die Arbeit wurde bisher 76-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, Timothy.Cripe@nationwidechildrens.org.
- Division of Hematology/Oncology/Blood and Marrow Transplantation, Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA, Timothy.Cripe@nationwidechildrens.org.
Förderung
- NCI NIH HHS
Zitieren
APA
Chen, C. Y., Hutzen, B., Wedekind, M. F., & Cripe, T. P. (2018). Oncolytic virus and PD-1/PD-L1 blockade combination therapy. Oncolytic Virotherapy, Volume 7, 65-77. https://doi.org/10.2147/ov.s145532
Vancouver
Chen CY, Hutzen B, Wedekind MF, Cripe TP. Oncolytic virus and PD-1/PD-L1 blockade combination therapy. Oncolytic Virotherapy. 2018;Volume 7:65-77. doi:10.2147/ov.s145532
BibTeX
@article{Chen2018,
author = {Chen, Chun-Yu and Hutzen, Brian and Wedekind, Mary F and Cripe, Timothy P},
title = {Oncolytic virus and PD-1/PD-L1 blockade combination therapy},
journal = {Oncolytic Virotherapy},
year = {2018},
volume = {Volume 7},
pages = {65--77},
doi = {10.2147/ov.s145532}
}
EUVIMED